XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Profit or Loss [Abstract]      
Research and development expenses $ (31) $ (30) $ (30)
General and administrative expenses (734) (850) (1,001)
Operating loss (765) (880) (1,031)
Revaluation of warrants to purchase ADS's 1,054 719
Revaluation of marketable securities (1,022) (1,531) 747
Other finance income 41 36 21
Other finance expenses (36) (27) (21)
Finance income (expenses), net (1,017) (468) 1,466
Total comprehensive income (loss) for the year $ (1,782) $ (1,348) $ 435
Basic earnings (loss) per share (in U.S. dollars): (in Dollars per share) $ (0.003) $ (0.002) $ 0.001
Diluted loss per share (in U.S. dollars): (in Dollars per share) $ (0.003) $ (0.002) $ 0
Weighted average number of issued ordinary shares (in Shares) 544,906,149 544,906,149 531,995,467
Diluted weighted average number of ordinary shares (in Shares) 544,906,149 544,909,149 615,548,446